Elanco Animal Health Inc

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 2. RESULTS OF OPERATIONS

Results of Operations

The following discussion and analysis of our results of operations should be read along with our condensed consolidated financial statements and the notes thereto. Our results of operations for the periods presented below may not be comparable with prior periods or with our results of operations in the future due to many factors, including but not limited to the factors identified above.

	Three Months Ended September 30,			Nine Months Ended September 30,
(Dollars in millions)	2026	2025	% Change	2026	2025	% Change
Revenue	$1,265	$1,137	11%	$4,004	$3,571	12%
Cost of sales	545	530	3%	1,701	1,567	9%
Gross profit	720	607	19%	2,303	2,004	15%
Research and development	99	89	11%	288	275	5%
Marketing, selling and administrative	393	351	12%	1,223	1,092	12%
Amortization of intangible assets	144	140	3%	421	404	4%
Asset impairment, restructuring and other special charges	3	25	NM	28	35	(20)%
Interest expense, net of capitalized interest	59	52	13%	175	140	25%
Other (income) expense, net	(2)	—	NM	1	23	NM
Income (loss) before income taxes	24	(50)	NM	167	35	377%
Income tax expense (benefit)	6	(16)	NM	38	(9)	NM
Net income (loss)	$18	$(34)	NM	$129	$44	193%

Certain amounts and percentages may reflect rounding adjustments.

NM - Not meaningful

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.